WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDrug Manufacturers - Specialty & Generic
Best Pharmaceutical Stocks to Buy Now (2024)
Top pharmaceutical stocks in 2024 ranked by overall Zen Score. See the best pharmaceutical stocks to buy now, according to analyst forecasts for the drug manufacturers - specialty & generic industry.

Industry: Drug Manufacturers - Spec...
Ticker
Company
Performance Score
Market Cap
Revenue
EBITDA
Earnings
EPS
Revenue Growth Y/Y
Revenue Growth 5Y
Earnings Growth Y/Y
Earnings Growth 5Y
Earnings Date
NBIX
NEUROCRINE BIOSCIENCES INC
$13.30B$1.89B$358.00M$249.70M$2.5626.76%33.13%59.01%61.92%2024-05-01
KMDA
KAMADA LTD
$293.15M$142.52M$22.44M$8.28M$0.1710.19%4.48%N/A-20.93%2024-05-22
SIGA
SIGA TECHNOLOGIES INC
$593.61M$139.92M$88.31M$68.07M$0.9526.31%-21.75%106.52%-29.04%2024-05-02
AMPH
AMPHASTAR PHARMACEUTICALS INC
$1.93B$644.40M$225.48M$137.55M$2.8529.14%16.94%51.60%N/A2024-05-07
PCRX
PACIRA BIOSCIENCES INC
$1.21B$674.98M$157.58M$41.96M$0.911.22%14.88%160.00%N/A2024-05-01
COLL
COLLEGIUM PHARMACEUTICAL INC
$1.11B$566.77M$308.33M$48.16M$1.4322.17%15.11%N/AN/A2024-05-02
HCM
HUTCHMED (CHINA) LTD
$2.95B$838.00MN/A$100.78M$0.6096.52%31.38%N/AN/A
LNTH
LANTHEUS HOLDINGS INC
$4.32B$1.30B$491.01M$326.66M$4.7938.65%30.44%1,068.29%35.21%2024-05-02
ZTS
ZOETIS INC
$66.64B$8.54B$3.67B$2.34B$5.085.74%7.96%12.64%11.41%2024-05-02
SCYX
SCYNEXIS INC
$54.37M$140.14M$70.89M$67.04M$1.402,652.72%252.64%N/AN/A2024-05-08
FTLF
FITLIFE BRANDS INC
$128.93M$52.70M$8.12M$5.30M$1.1882.97%25.28%21.65%66.58%2024-05-13
ANIP
ANI PHARMACEUTICALS INC
$1.38B$486.82M$107.87M$17.15M$0.8653.87%19.28%N/A-8.07%2024-05-10
RDY
DR REDDYS LABORATORIES LTD
$12.01B$2.99B$904.61M$547.73MN/A6.32%6.52%N/AN/A2024-05-22
PAHC
PHIBRO ANIMAL HEALTH CORP
$528.57M$982.01M$80.57M$14.80M$0.371.02%3.20%-58.89%-27.12%2024-05-09
ALKS
ALKERMES PLC
$4.02B$1.66B$356.08M$355.76M$2.1449.61%8.74%N/AN/A2024-05-01
SUPN
SUPERNUS PHARMACEUTICALS INC
$1.63B$607.52M$90.04M$1.32M$0.02-8.95%8.24%-98.23%-60.69%2024-05-07
CRON
CRONOS GROUP INC
$899.87M$87.24M-$120.32M-$73.96M-$0.190.57%48.40%N/AN/A2024-05-07
ITCI
INTRA-CELLULAR THERAPIES INC
$7.22B$464.37M-$138.51M-$139.67M-$1.4685.51%N/AN/AN/A2024-05-02
EOLS
EVOLUS INC
$679.10M$202.09M-$41.81M-$61.69M-$1.0835.98%N/AN/AN/A2024-05-07
ZOM
ZOMEDICA CORP
$127.39M$25.19M-$33.96M-$33.64M-$0.0433.05%N/AN/AN/A2024-05-09
DCPH
DECIPHERA PHARMACEUTICALS INC
$1.18B$163.36M-$187.94M-$194.94M-$2.2921.87%N/AN/AN/A2024-05-01
PROC
PROCAPS GROUP SA
$305.75M$414.10M$75.58M$52.20M$0.52-4.80%N/A-13.33%N/A2024-05-09
SBFM
SUNSHINE BIOPHARMA INC
$1.43M$24.09M-$3.82M-$4.51M-$19.00454.42%N/AN/AN/A2024-05-09
HLN
HALEON PLC
$38.60B$14.31B$2.70B$1.33B$0.299.36%N/A4.33%N/A2024-05-01
ACB
AURORA CANNABIS INC
$298.87M$199.23M-$66.17M-$106.90M-$3.9630.77%17.87%N/AN/A2024-06-12
ETON
ETON PHARMACEUTICALS INC
$83.49M$32.64M-$291.00k-$936.00k-$0.0442.60%N/AN/AN/A2024-05-09
EGRX
EAGLE PHARMACEUTICALS INC
$59.09M$257.55M$57.18M$11.95M$0.92-5.38%3.61%-49.73%-14.47%2024-05-07
TLRY
TILRAY BRANDS INC
$1.33B$743.25M-$186.62M-$351.95M-$0.4424.65%30.54%N/AN/A
GHSI
GUARDION HEALTH SCIENCES INC
$10.27M$12.25M$177.45k$158.03k$0.1210.85%67.03%N/AN/A2024-05-13
TARO
TARO PHARMACEUTICAL INDUSTRIES LTD
$1.59B$610.83MN/A$45.70M$1.227.23%-1.69%0.00%-31.12%2024-05-21
OPTN
OPTINOSE INC
$116.03M$70.99M-$15.55M-$35.48M-$0.32-6.93%58.64%N/AN/A2024-05-09
DVAX
DYNAVAX TECHNOLOGIES CORP
$1.55B$232.28M$9.67M-$6.39M-$0.05-67.86%95.19%N/AN/A2024-04-30
TLPH
TALPHERA INC
$15.78M$651.00k-$17.95M-$18.40M-$1.29N/A-21.26%N/AN/A2024-05-08
AQST
AQUESTIVE THERAPEUTICS INC
$321.06M$50.58M$1.18M-$7.87M-$0.136.09%-5.59%N/AN/A2024-04-30
VTRS
VIATRIS INC
$13.36B$15.43B$3.52B$54.70M$0.05-5.14%6.17%-97.08%-40.84%2024-05-06
QLI
QILIAN INTERNATIONAL HOLDING GROUP LTD
$27.17M$46.47M-$6.52M-$7.78M-$0.22-28.35%-1.60%N/AN/A
PRGO
PERRIGO CO PLC
$4.07B$4.66B$516.70M-$12.70M-$0.094.58%-0.32%N/AN/A2024-05-07
TXMD
THERAPEUTICSMD INC
$21.68M$1.30M-$9.40M-$10.28M-$0.98-98.14%-39.53%N/AN/A2024-05-13
TKNO
ALPHA TEKNOVA INC
$81.65M$36.68M-$30.45M-$36.78M-$1.16-11.43%N/AN/AN/A2024-05-08
ORGO
ORGANOGENESIS HOLDINGS INC
$391.93M$433.14M$36.03M$4.95M$0.04-3.94%17.49%-66.67%N/A2024-05-08
PTPI
PETROS PHARMACEUTICALS INC
$4.47M$5.82M-$4.21M-$13.81M-$6.35-2.83%N/AN/AN/A
DRRX
DURECT CORP
$24.98M$8.55M-$24.80M-$27.62M-$1.05-55.67%-10.96%N/AN/A2024-05-06
RMTI
ROCKWELL MEDICAL INC
$44.44M$83.61M-$2.68M-$8.44M-$0.3714.84%5.69%N/AN/A2024-05-14
CLVR
CLEVER LEAVES HOLDINGS INC
$6.73M$17.42M-$14.94M-$17.90M-$11.426.14%N/AN/AN/A2024-05-09
AYTU
AYTU BIOPHARMA INC
$15.64M$98.50M-$8.45M-$18.00M-$3.85-6.71%83.31%N/AN/A2024-05-09
YCBD
CBDMD INC
$2.97M$23.45M-$17.13M-$23.98M-$12.63-27.11%150.64%N/AN/A2024-05-13
ESPR
ESPERION THERAPEUTICS INC
$353.45M$116.33M-$150.11M-$209.25M-$2.0354.14%N/AN/AN/A2024-05-07
BFRI
BIOFRONTERA INC
$7.35M$34.07M-$18.59M-$20.13M-$13.0218.82%N/AN/AN/A2024-05-12
UPC
UNIVERSE PHARMACEUTICALS INC
$7.11M$32.31M-$3.18M-$6.16M-$1.70-19.52%N/AN/AN/A
PRFX
PAINREFORM LTD
$1.47M$0.00-$9.57M-$9.34M-$7.14N/AN/AN/AN/A2024-05-13
EVOK
EVOKE PHARMA INC
$3.86M$5.18M-$7.16M-$7.79M-$2.33106.51%N/AN/AN/A2024-05-13
ASRT
ASSERTIO HOLDINGS INC
$82.17M$152.07M-$222.45M-$331.94M-$4.67-2.67%-13.38%N/AN/A2024-05-07
RDHL
REDHILL BIOPHARMA LTD
$16.90M$6.53M$14.62M$23.92M$4.00-89.43%-4.82%N/AN/A2024-06-10
AVDL
AVADEL PHARMACEUTICALS PLC
$1.57B$27.96M-$149.13M-$160.28M-$2.00N/A-22.99%N/AN/A2024-05-06
HROW
HARROW INC
$374.84M$130.19M$9.95M-$24.41M-$0.7546.95%25.77%N/AN/A2024-05-09
DERM
JOURNEY MEDICAL CORP
$70.56M$79.18M$1.92M-$3.85M-$0.217.48%N/AN/AN/A2024-05-20
HUGE
FSD PHARMA INC
$19.26M$0.00-$11.32M-$13.16M-$0.34N/AN/AN/AN/A2024-05-10
SXTC
CHINA SXT PHARMACEUTICALS INC
$771.52k$29.92k-$13.36M-$14.14M-$26.97-91.18%-27.77%N/AN/A
INCR
INTERCURE LTD
$115.30M$109.73MN/A$4.29MN/A20.43%N/AN/AN/A
COSM
COSMOS HEALTH INC
$6.58M$49.59M-$12.79M-$42.91M-$4.31-8.97%4.62%N/AN/A2024-05-15
CRDL
CARDIOL THERAPEUTICS INC
$115.02M$0.00-$20.50M-$20.68M-$0.32N/AN/AN/AN/A2024-05-17
CGC
CANOPY GROWTH CORP
$715.25M$246.67M-$907.84M-$952.65M-$16.21-10.51%16.69%N/AN/A2024-06-20
TAK
TAKEDA PHARMACEUTICAL CO LTD
$41.92B$28.38B$7.34B$1.21B$0.39-0.57%12.67%-39.40%-8.81%2024-05-09
INDV
INDIVIOR PLC
$2.53B$1.09B$67.00M$2.00M$0.0121.31%-0.40%N/A-67.60%2024-04-25
AKAN
AKANDA CORP
$366.67k$3.94M-$10.41M-$14.94M-$4.363,466.29%N/AN/AN/A
PETQ
PETIQ INC
$485.91M$1.10B$81.00M$2.13M$0.0719.58%15.83%N/AN/A2024-05-07
FLGC
FLORA GROWTH CORP
$14.74M$76.07M-$55.40M-$56.35M-$7.75127.75%N/AN/AN/A
OGI
ORGANIGRAM HOLDINGS INC
$154.21MN/AN/AN/AN/AN/AN/AN/AN/A
IXHL
INCANNEX HEALTHCARE INC
$37.30M$0.00N/A-$17.42M-$1.07N/AN/AN/AN/A
LFCR
LIFECORE BIOMEDICAL INC
$192.14M$103.27M-$68.32M-$99.56M-$3.32-7.19%-27.74%N/AN/A2024-05-30
KALA
KALA BIO INC
$17.83M$0.00-$35.91M-$42.20M-$17.35-100.00%N/AN/AN/A2024-05-07
CPIX
CUMBERLAND PHARMACEUTICALS INC
$22.97M$39.55M$204.76k-$6.28M-$0.44-5.85%6.15%N/AN/A2024-05-07
CPHI
CHINA PHARMA HOLDINGS INC
$4.70M$7.01M$8.44k-$3.08M-$0.91-13.48%-10.68%N/AN/A
EBS
EMERGENT BIOSOLUTIONS INC
$112.76M$1.05B-$518.20M-$760.50M-$14.85-6.10%6.05%N/AN/A2024-05-07
RGC
REGENCELL BIOSCIENCE HOLDINGS LTD
$83.80M$0.00-$5.10M-$5.87M-$0.45N/AN/AN/AN/A
IRWD
IRONWOOD PHARMACEUTICALS INC
$1.26B$442.74M-$895.55M-$1.00B-$6.457.83%5.02%N/AN/A2024-05-02
SNOA
SONOMA PHARMACEUTICALS INC
$2.45M$12.31M-$4.95M-$5.08M-$0.94-1.96%-7.57%N/AN/A2024-06-19
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
$14.44B$15.85B$1.64B-$559.00M-$0.506.17%-2.81%N/AN/A2024-05-01
AMRX
AMNEAL PHARMACEUTICALS INC
$1.65B$2.39B$364.49M-$83.99M-$0.488.20%7.56%N/AN/A2024-05-03
SHPH
SHUTTLE PHARMACEUTICALS HOLDINGS INC
$6.50M$0.00-$4.09M-$6.59M-$0.44N/AN/AN/AN/A
ALVO
ALVOTECH
$3.56B$93.38M-$359.68M-$551.73M-$2.439.84%N/AN/AN/A2024-05-22
CYTH
CYCLO THERAPEUTICS INC
$36.18M$1.08M-$20.04M-$20.06M-$1.23-21.76%1.25%N/AN/A2024-05-13
EVO
EVOTEC SE
$2.61BN/AN/AN/AN/AN/AN/AN/AN/A2024-04-24
ALIM
ALIMERA SCIENCES INC
$185.33M$80.75M-$1.12M-$21.39M-$0.8449.19%11.62%N/AN/A2024-05-13
BHC
BAUSCH HEALTH COMPANIES INC
$3.09B$8.76B$2.22B-$592.00M-$1.627.79%0.88%N/AN/A2024-05-02
ELAN
ELANCO ANIMAL HEALTH INC
$6.37B$4.42B-$224.00M-$1.23B-$2.500.14%7.57%N/AN/A2024-05-08
CTLT
CATALENT INC
$10.13B$4.10B-$754.00M-$1.30B-$7.19-13.38%10.50%N/AN/A2024-05-17
PBH
PRESTIGE CONSUMER HEALTHCARE INC
$3.47B$1.13B$16.86M-$80.67M-$1.602.29%2.74%N/AN/A2024-05-02
LSDI
LUCY SCIENTIFIC DISCOVERY INC
$1.99M$16.73k-$9.75M-$11.30M-$7.00N/AN/AN/AN/A
BGXX
BRIGHT GREEN CORP
$37.65M$0.00-$12.49M-$13.13M-$0.07N/AN/AN/AN/A

Pharmaceutical Stocks FAQ

What are the best pharmaceutical stocks to buy right now in Apr 2024?

According to Zen Score, the 3 best pharma stocks to buy right now are:

1. Neurocrine Biosciences (NASDAQ:NBIX)


Neurocrine Biosciences (NASDAQ:NBIX) is the top pharmaceutical stock with a Zen Score of 64, which is 39 points higher than the pharmaceutical industry average of 25. It passed 21 out of 33 due diligence checks and has strong fundamentals. Neurocrine Biosciences has seen its stock return 29.07% over the past year, overperforming other pharmaceutical stocks by 40 percentage points.

Neurocrine Biosciences has an average 1 year price target of $142.44, an upside of 6.57% from Neurocrine Biosciences's current stock price of $133.66.

Neurocrine Biosciences stock has a consensus Buy recommendation according to Wall Street analysts. Of the 16 analysts covering Neurocrine Biosciences, 43.75% have issued a Strong Buy rating, 18.75% have issued a Buy, 37.5% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Kamada (NASDAQ:KMDA)


Kamada (NASDAQ:KMDA) is the second best pharmaceutical stock with a Zen Score of 63, which is 38 points higher than the pharmaceutical industry average of 25. It passed 20 out of 33 due diligence checks and has strong fundamentals. Kamada has seen its stock return 13.08% over the past year, overperforming other pharmaceutical stocks by 24 percentage points.

Kamada has an average 1 year price target of $11.00, an upside of 115.69% from Kamada's current stock price of $5.10.

Kamada stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Kamada, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Siga Technologies (NASDAQ:SIGA)


Siga Technologies (NASDAQ:SIGA) is the third best pharmaceutical stock with a Zen Score of 58, which is 33 points higher than the pharmaceutical industry average of 25. It passed 21 out of 38 due diligence checks and has strong fundamentals. Siga Technologies has seen its stock return 46.49% over the past year, overperforming other pharmaceutical stocks by 58 percentage points.

What are the pharmaceutical stocks with highest dividends?

Out of 6 pharmaceutical stocks that have issued dividends in the past year, the 3 pharmaceutical stocks with the highest dividend yields are:

1. Siga Technologies (NASDAQ:SIGA)


Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 12.57%, which is 9 percentage points higher than the pharmaceutical industry average of 3.69%.

Siga Technologies's dividend payout ratio of 47.4% indicates that its high dividend yield is sustainable for the long-term.

2. Alkermes (NASDAQ:ALKS)


Alkermes (NASDAQ:ALKS) has an annual dividend yield of 4.45%, which is 1 percentage points higher than the pharmaceutical industry average of 3.69%.

Alkermes's dividend payout ratio of 50% indicates that its dividend yield is sustainable for the long-term.

3. Phibro Animal Health (NASDAQ:PAHC)


Phibro Animal Health (NASDAQ:PAHC) has an annual dividend yield of 3.68%, which is the same as the pharmaceutical industry average of 3.69%. Phibro Animal Health's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Phibro Animal Health's dividend has shown consistent growth over the last 10 years.

Phibro Animal Health's dividend payout ratio of 129.7% indicates that its dividend yield might not be sustainable for the long-term.

Why are pharmaceutical stocks up?

Pharmaceutical stocks were up 0.32% in the last day, and up 0.07% over the last week.

We couldn't find a catalyst for why pharmaceutical stocks are up.

What are the most undervalued pharmaceutical stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued pharmaceutical stocks right now are:

1. Kamada (NASDAQ:KMDA)


Kamada (NASDAQ:KMDA) is the most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Kamada has a valuation score of 86, which is 67 points higher than the pharmaceutical industry average of 19. It passed 6 out of 7 valuation due diligence checks.

Kamada's stock has gained 13.08% in the past year. It has overperformed other stocks in the pharmaceutical industry by 24 percentage points.

2. Collegium Pharmaceutical (NASDAQ:COLL)


Collegium Pharmaceutical (NASDAQ:COLL) is the second most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Collegium Pharmaceutical has a valuation score of 86, which is 67 points higher than the pharmaceutical industry average of 19. It passed 6 out of 7 valuation due diligence checks.

Collegium Pharmaceutical's stock has gained 48.46% in the past year. It has overperformed other stocks in the pharmaceutical industry by 60 percentage points.

3. Pacira Biosciences (NASDAQ:PCRX)


Pacira Biosciences (NASDAQ:PCRX) is the third most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 86, which is 67 points higher than the pharmaceutical industry average of 19. It passed 6 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -42.99% in the past year. It has underperformed other stocks in the pharmaceutical industry by -32 percentage points.

Are pharmaceutical stocks a good buy now?

54.9% of pharmaceutical stocks rated by analysts are a strong buy right now. On average, analysts expect pharmaceutical stocks to rise by 41.11% over the next year.

What is the average p/e ratio of the drug manufacturers - specialty & generic industry?

The average P/E ratio of the drug manufacturers - specialty & generic industry is 46.47x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.